The Oncology Institute, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↓-4.7% -$8M
$165M
Current Assets↑+0.3% +$329K
$113M
Cash & Equivalents
—
ST Investments
$0
Receivables↑+22.1% +$11M
$59M
Inventory↑+68.1% +$7M
$17M
Net PPE↓-10.1% -$1M
$11M
Goodwill↑+0.0% +$0
$7M
Intangibles↓-25.6% -$4M
$11M
Total Liabilities↑+6.7% +$11M
$180M
Current Liabilities↑+35.9% +$19M
$71M
Account Payables↑+77.5% +$19M
$43M
Long-Term Debt↓-16.9% -$16M
$77M
Short-Term Debt
—
Stockholders Equity↓-538.0% -$19M
$-16M
Retained Earnings↓-28.7% -$61M
$-271M
Operating Lease ROU Asset↓-13.2% -$3M
$22M
Operating Lease Liability↑+13.2% +$3M
$26M
Accumulated Depreciation↑+56.7% +$4M
$11M
Debt Due Y1
$0
Debt Due Y2
$86M
Debt Due Y3
$110M
Debt Due Y4
—
Debt Due Y5
—
Total Debt Carrying Amount↓-21.9% -$24M
$86M
Contract Asset
$0
Contract Liability↓-2.9% -$69K
$2M
Contract Liability (Current)↓-2.9% -$69K
$2M